Note 18  Stock Based Compensation

 

The Company’s stockholders approved the 2017 Equity Compensation Plan (“the Plan”) on May 23, 2017. The Plan eliminates all remaining issuable shares under previous plans and is the only outstanding plan as of December 31, 2025. On May 30, 2023, the Company's stockholders approved an amendment to the Plan that increased the maximum number of shares issuable to 1,200,000. Grants under the Plan can be in the form of stock options (qualified or non-qualified), restricted shares, deferred stock units or performance units. Shares available for grant and issuance under the Plan as of December 31, 2025 are approximately 169,899. The Company intends to issue all shares under the Plan in the form of newly issued shares.

 

As of both December 31, 2025 and December 31, 2024, the Company did not have any outstanding stock options. Restricted stock and deferred stock units typically have a three-year vesting period starting one year after the date of grant with one-third vesting each year. Restricted stock granted to new employees and board members may be granted with shorter vesting periods. Grants of performance units typically have a cliff vesting after three years or upon a change of control. All issuances are subject to forfeiture if the recipient leaves or is terminated prior to the awards vesting. Restricted shares have the same dividend and voting rights as common stock, while options, performance units and deferred stock units do not.

 

All awards are issued at the fair value of the underlying shares at the grant date. The Company expenses the cost of the awards, which is determined to be the fair market value of the awards at the date of grant, ratably over the vesting period. Forfeiture rates are not estimated but are recorded as incurred. Stock-based compensation expense was $4.6 million, $4.6 million and $4.9 million for the years ended December 31, 2025, 2024 and 2023, respectively.

 

Activity under the Company’s restricted shares for year ended December 31, 2025 was as follows:

 

      

Weighted-

 
      

Average

 
  

Nonvested

  

Grant Date

 
  

Shares

  

Fair Value

 

Nonvested as of December 31, 2024

  110,340  $18.26 

Granted

  75,525   23.50 

Vested

  (71,642)  20.61 

Forfeited

  (3,874)  20.40 

Nonvested December 31, 2025

  110,349   20.25 

 

 

As of December 31, 2025, there was approximately $0.9 million of total unrecognized compensation cost related to nonvested restricted shares granted. The cost is expected to be recognized over a weighted average period of 1.1 years.

 

A summary of the status of unearned performance unit awards and the change during the period is presented in the table below:

 

          

Weighted

 
          

Average Grant

 
  

Units

  

Units

  

Date Fair

 
  

(expected)

  

(maximum)

  

Value

 

Unearned as of December 31, 2024

  189,672      $21.52 

Awarded

  88,681       24.01 

Change in estimate (decrease)

  (19,616)      17.93 

Change in estimate (increase)

  4,197       32.80 

Vested shares

  (43,331)      32.80 

Forfeited/cancelled/expired

  (3,452)      19.01 

Unearned as of December 31, 2025

  216,151   371,976   20.87 

 

As of December 31, 2025, the specific number of shares related to performance units that were expected to vest was 216,151, determined by actual performance in consideration of the established range of the performance targets, which is consistent with the level of expense currently being recognized over the vesting period. Should this expectation change, additional compensation expense could be recorded in future periods or previously recognized expense could be reversed. As of December 31, 2025, the maximum number of performance units that ultimately could vest if performance targets were exceeded is 371,976. During the year ended December 31, 2025, 43,331 shares vested. A total of 23,754 shares were netted from the vested shares to satisfy employee tax obligations. The net shares issued from vesting of performance units during the year ended December 31, 2025 were 19,577 shares. As of December 31, 2025, compensation cost of approximately $2.0 million related to non-vested performance units not yet recognized is expected to be recognized over a weighted-average period of 1.7 years.

 

A summary of the status of unearned deferred stock units and the changes in deferred stock units during the period is presented in the table below:

 

      

Weighted

 
      

Average Grant

 
  

Units

  

Date Fair

 
  

(expected)

  

Value

 

Unearned as of December 31, 2024

  181,836  $20.32 

Awarded

  80,010   24.01 

Vested shares

  (91,364)  21.35 

Unearned as of December 31, 2025

  170,482  $21.50 

 

Any shares cancelled would result in previously recognized expense being reversed. A portion of the shares that vest will be netted out to satisfy the tax obligations of the recipient. During the year ended December 31, 2025, 91,364 shares vested. A total of 48,743 shares were netted from the vested shares to satisfy employee tax obligations. The net shares issued from vesting of deferred stock units during the year ended December 31, 2025 were 42,621 shares. As of December 31, 2025, compensation cost of approximately $1.2 million related to non-vested deferred stock units, not yet recognized, is expected to be recognized over a weighted-average period of 1.4 years.

 

Historical Timeline

Fiscal YearFiled
2025Feb 24, 2026Showing above
2024Feb 21, 2025
2023Feb 23, 2024
2022Feb 24, 2023
2019Mar 2, 2020
2018Feb 28, 2019
2016Mar 10, 2017
2015Mar 4, 2016

About Stock Compensation Disclosures

Stock-based compensation disclosures detail the equity awards granted to employees and executives — including stock options, restricted stock units (RSUs), and performance shares — along with the valuation methods and assumptions used to expense them. This section reveals the true cost of talent retention and the alignment between management incentives and shareholder interests.

Key signals: total unrecognized compensation expense and its expected recognition period signal future earnings headwinds from already-granted awards. For stock options, examine Black-Scholes assumptions — expected volatility, risk-free rate, and expected term — as understating any of these reduces reported compensation expense. Compare stock compensation expense as a percentage of revenue against peers to assess dilution cost. Watch vesting schedules for acceleration clauses tied to change-of-control events. Performance-based awards with undemanding targets may indicate weak governance. Add back stock compensation to operating cash flow to calculate a more conservative free cash flow figure.